Search

Bong-sook Baek

Examiner (ID: 15901, Phone: (571)270-5863 , Office: P/1621 )

Most Active Art Unit
1611
Art Unit(s)
1629, 1611, 1614, 1621, 4161
Total Applications
1160
Issued Applications
484
Pending Applications
95
Abandoned Applications
604

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20307845 [patent_doc_number] => 20250325474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-23 [patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 19/254167 [patent_app_country] => US [patent_app_date] => 2025-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 400 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19254167 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/254167
AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION Jun 29, 2025 Pending
Array ( [id] => 20048155 [patent_doc_number] => 20250186377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM [patent_app_type] => utility [patent_app_number] => 19/056265 [patent_app_country] => US [patent_app_date] => 2025-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14473 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19056265 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/056265
METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM Feb 17, 2025 Abandoned
Array ( [id] => 19875789 [patent_doc_number] => 20250108046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY [patent_app_type] => utility [patent_app_number] => 18/977526 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38503 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977526 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/977526
APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY Dec 10, 2024 Pending
Array ( [id] => 19875789 [patent_doc_number] => 20250108046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY [patent_app_type] => utility [patent_app_number] => 18/977526 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38503 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977526 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/977526
APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY Dec 10, 2024 Pending
Array ( [id] => 20356257 [patent_doc_number] => 12472236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Compositions and methods for treating diabetes [patent_app_type] => utility [patent_app_number] => 18/967455 [patent_app_country] => US [patent_app_date] => 2024-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 21784 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18967455 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/967455
Compositions and methods for treating diabetes Dec 2, 2024 Issued
Array ( [id] => 19798801 [patent_doc_number] => 20250064726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/944456 [patent_app_country] => US [patent_app_date] => 2024-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18944456 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/944456
Aqueous suspension suitable for oral administration Nov 11, 2024 Issued
Array ( [id] => 19798801 [patent_doc_number] => 20250064726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/944456 [patent_app_country] => US [patent_app_date] => 2024-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18944456 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/944456
Aqueous suspension suitable for oral administration Nov 11, 2024 Issued
Array ( [id] => 19875799 [patent_doc_number] => 20250108056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE [patent_app_type] => utility [patent_app_number] => 18/749901 [patent_app_country] => US [patent_app_date] => 2024-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18749901 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/749901
SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE Jun 20, 2024 Pending
Array ( [id] => 19707756 [patent_doc_number] => 20250017898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => COMPOSITIONS AND METHODS FOR ACTIVATING NRF2-DEPENDENT GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/739544 [patent_app_country] => US [patent_app_date] => 2024-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19698 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18739544 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/739544
COMPOSITIONS AND METHODS FOR ACTIVATING NRF2-DEPENDENT GENE EXPRESSION Jun 10, 2024 Pending
Array ( [id] => 19447203 [patent_doc_number] => 20240307333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/737662 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737662 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/737662
ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF Jun 6, 2024 Pending
Array ( [id] => 19613046 [patent_doc_number] => 20240398726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => SOLUBLE CURCUMIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 18/732567 [patent_app_country] => US [patent_app_date] => 2024-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732567 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/732567
SOLUBLE CURCUMIN AND ITS DERIVATIVES Jun 2, 2024 Pending
Array ( [id] => 19447247 [patent_doc_number] => 20240307377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT [patent_app_type] => utility [patent_app_number] => 18/670599 [patent_app_country] => US [patent_app_date] => 2024-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670599 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/670599
METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT May 20, 2024 Abandoned
Array ( [id] => 19360762 [patent_doc_number] => 20240262796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/620876 [patent_app_country] => US [patent_app_date] => 2024-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29540 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620876 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/620876
SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE Mar 27, 2024 Pending
Array ( [id] => 19360762 [patent_doc_number] => 20240262796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/620876 [patent_app_country] => US [patent_app_date] => 2024-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29540 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620876 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/620876
SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE Mar 27, 2024 Pending
Array ( [id] => 19477334 [patent_doc_number] => 20240325376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => COMPOSITIONS AND METHODS FOR ADMINISTERING PALTUSOTINE TO PATIENTS WITH HEPATIC IMPAIRMENT [patent_app_type] => utility [patent_app_number] => 18/615512 [patent_app_country] => US [patent_app_date] => 2024-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18615512 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/615512
Compositions and methods for administering paltusotine to patients with hepatic impairment Mar 24, 2024 Issued
Array ( [id] => 19297491 [patent_doc_number] => 20240226056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => Sleep or Post-Sleep Performance [patent_app_type] => utility [patent_app_number] => 18/613524 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613524 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/613524
Sleep or Post-Sleep Performance Mar 21, 2024 Pending
Array ( [id] => 19578724 [patent_doc_number] => 12144806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-19 [patent_title] => Quinolines that modulate SERCA and their use for treating disease [patent_app_type] => utility [patent_app_number] => 18/588191 [patent_app_country] => US [patent_app_date] => 2024-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 25480 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18588191 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/588191
Quinolines that modulate SERCA and their use for treating disease Feb 26, 2024 Issued
Array ( [id] => 20039229 [patent_doc_number] => 20250177451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => EXTRACELLULAR VESICLES FOR THERAPY [patent_app_type] => utility [patent_app_number] => 18/581843 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581843 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/581843
EXTRACELLULAR VESICLES FOR THERAPY Feb 19, 2024 Pending
Array ( [id] => 20039229 [patent_doc_number] => 20250177451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => EXTRACELLULAR VESICLES FOR THERAPY [patent_app_type] => utility [patent_app_number] => 18/581843 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581843 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/581843
EXTRACELLULAR VESICLES FOR THERAPY Feb 19, 2024 Pending
Array ( [id] => 19201353 [patent_doc_number] => 20240173252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => AQUEOUS SUSPENSION SUITABLE FOR ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/426972 [patent_app_country] => US [patent_app_date] => 2024-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18426972 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/426972
Aqueous suspension suitable for oral administration Jan 29, 2024 Issued
Menu